674 results on '"Jakesz, Raimund"'
Search Results
2. Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
3. The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study
4. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
5. Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34
6. Resilienz: der Weg der Krankheitsbewältigung
7. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
8. Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial
9. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
10. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
11. Estradiol-BSA Conjugates for Estrogen Receptor Localization: the Vienna Experience
12. Data from A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
13. Supplementary Table 1 from The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
14. Supplementary Appendix, Tables 1-8, Figures 1-9 from A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
15. Abstract P2-11-15: Focal ESR1 gene amplification is an independent prognostic marker in postmenopausal patients with endocrine-responsive early breast cancer
16. Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy
17. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
18. Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials
19. Die Chirurgie des Mammacarcinoms
20. Quality of life after sympathetic surgery at the T4 ganglion for primary hyperhidrosis: Clip application versus diathermic cut
21. Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
22. Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification
23. p53 as a Prognostic and Predictive Indicator
24. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression:a patient-level meta-analysis of 7030 women from four randomised trials
25. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li–Fraumeni family
26. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
27. NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
28. Maintaining Bone Density in Patients Undergoing Treatment for Breast Cancer: Is There an Adjuvant Benefit?
29. Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction
30. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
31. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer
32. Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
33. Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients
34. Surgery for liver metastases originating from sarcoma—case series
35. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
36. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases
37. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
38. Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis
39. Bisphosphonates as adjuvant therapy for breast cancer
40. Endocrine therapy plus zoledronic acid in premenopausal breast cancer
41. Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative
42. Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)
43. The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)
44. Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF
45. Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients
46. Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
47. Predictors for Complications after Loop Stoma Closure in Patients with Rectal Cancer
48. Preoperative Core Needle Biopsy does not Increase Local Recurrence Rate in Breast Cancer Patients
49. Does Gastric Dilatation Limit the Success of Sleeve Gastrectomy as a Sole Operation for Morbid Obesity?
50. Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.